{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T13:10:37Z","timestamp":1789132237965,"version":"build-2803163510"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,2,18]],"date-time":"2020-02-18T00:00:00Z","timestamp":1581984000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81171193"],"award-info":[{"award-number":["81171193"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81671108"],"award-info":[{"award-number":["81671108"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81873734"],"award-info":[{"award-number":["81873734"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81974200"],"award-info":[{"award-number":["81974200"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Key R&D Program of China","award":["2017YFC1310300"],"award-info":[{"award-number":["2017YFC1310300"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.nbd.2020.104807","type":"journal-article","created":{"date-parts":[[2020,2,21]],"date-time":"2020-02-21T04:27:17Z","timestamp":1582259237000},"page":"104807","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Distinct anti-dyskinetic effects of amantadine and group II metabotropic glutamate receptor agonist LY354740 in a rodent model: An electrophysiological perspective"],"prefix":"10.1016","volume":"139","author":[{"given":"Cong","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guiqin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiqi","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoman","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3776-2749","authenticated-orcid":false,"given":"Shuke","family":"Nie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhentao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuebing","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2020.104807_bb0005","doi-asserted-by":"crossref","first-page":"9134","DOI":"10.1523\/JNEUROSCI.22-20-09134.2002","article-title":"The origin and neuronal function of in vivo nonsynaptic glutamate","volume":"22","author":"Baker","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2020.104807_bb0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v031.i10","article-title":"CircStat: a MATLAB toolbox for circular statistics","volume":"31","author":"Berens","year":"2009","journal-title":"J. Stat. Softw."},{"key":"10.1016\/j.nbd.2020.104807_bb0015","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1111\/j.1471-4159.2011.07376.x","article-title":"Amantadine attenuates levodopa-induced dyskinesia in mice and rats preventing the accompanying rise in nigral GABA levels","volume":"118","author":"Bido","year":"2011","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2020.104807_bb0020","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/0006-8993(95)00690-R","article-title":"MK-801 reverses effects of chronic levodopa on D1 and D2 dopamine agonist-induced rotational behavior","volume":"692","author":"Boldry","year":"1995","journal-title":"Brain Res."},{"key":"10.1016\/j.nbd.2020.104807_bb0025","doi-asserted-by":"crossref","first-page":"3085","DOI":"10.1523\/JNEUROSCI.20-09-03085.2000","article-title":"Activation of group II metabotropic glutamate receptors inhibits synaptic excitation of the substantia Nigra pars reticulata","volume":"20","author":"Bradley","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2020.104807_bb0030","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1002\/mds.20612","article-title":"Nondopaminergic mechanisms in levodopa-induced dyskinesia","volume":"20","author":"Brotchie","year":"2005","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2020.104807_bb0035","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1038\/nn.3743","article-title":"Direct and indirect pathways of basal ganglia: a critical reappraisal","volume":"17","author":"Calabresi","year":"2014","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.nbd.2020.104807_bb0040","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1007\/s00702-018-1886-0","article-title":"On the neuronal circuitry mediating l-DOPA-induced dyskinesia","volume":"125","author":"Cenci","year":"2018","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.nbd.2020.104807_bb0045","doi-asserted-by":"crossref","first-page":"112","DOI":"10.3389\/fnins.2017.00112","article-title":"Antidyskinetic effects of MEK inhibitor are associated with multiple neurochemical alterations in the striatum of Hemiparkinsonian rats","volume":"11","author":"Chen","year":"2017","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.nbd.2020.104807_bb0050","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/nrn1763","article-title":"Metabotropic glutamate receptors in the basal ganglia motor circuit","volume":"6","author":"Conn","year":"2005","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.nbd.2020.104807_bb0055","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1523\/JNEUROSCI.19-01-00274.1999","article-title":"Oscillatory coupling of hippocampal pyramidal cells and interneurons in the behaving rat","volume":"19","author":"Csicsvari","year":"1999","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2020.104807_bb0060","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1038\/nn.3997","article-title":"Therapeutic deep brain stimulation reduces cortical phase-amplitude coupling in Parkinson\u2019s disease","volume":"18","author":"De Hemptinne","year":"2015","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.nbd.2020.104807_bb0065","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.expneurol.2011.02.012","article-title":"Local modulation of striatal glutamate efflux by serotonin 1A receptor stimulation in dyskinetic, hemiparkinsonian rats","volume":"229","author":"Dupre","year":"2011","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.nbd.2020.104807_bb0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nbd.2015.11.009","article-title":"Effects of L-dopa priming on cortical high beta and high gamma oscillatory activity in a rodent model of Parkinson\u2019s disease","volume":"86","author":"Dupre","year":"2016","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2020.104807_bb0075","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/s41582-019-0155-7","article-title":"Emerging therapies in Parkinson disease\u2014repurposed drugs and new approaches","volume":"15","author":"Elkouzi","year":"2019","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.nbd.2020.104807_bb0080","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1124\/jpet.108.136861","article-title":"Evidence for the role of metabotropic glutamate (mGlu)2 not mGlu3 receptors in the preclinical antipsychotic pharmacology of the mGlu2\/3 receptor agonist (\u2212)-(1R,4S,5S,6S)-4-amino-2-sulfonylbicyclo[3.1.0]hexane-4,6-dicarboxylic acid (LY404039)","volume":"326","author":"Fell","year":"2008","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.nbd.2020.104807_bb0085","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1016\/j.neuropharm.2011.06.007","article-title":"Group II metabotropic glutamate receptor agonists and positive allosteric modulators as novel treatments for schizophrenia","volume":"62","author":"Fell","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.nbd.2020.104807_bb0090","doi-asserted-by":"crossref","first-page":"10068","DOI":"10.1038\/s41598-018-28273-5","article-title":"Striatonigral neurons divide into two distinct morphological-physiological phenotypes after chronic L-DOPA treatment in parkinsonian rats","volume":"8","author":"Fieblinger","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.nbd.2020.104807_bb0095","first-page":"196028","article-title":"Metabotropic glutamate receptors for Parkinson's disease therapy","volume":"2013","author":"Gasparini","year":"2013","journal-title":"Parkinsons Dis."},{"key":"10.1016\/j.nbd.2020.104807_bb0100","doi-asserted-by":"crossref","first-page":"6900","DOI":"10.1523\/JNEUROSCI.22-16-06900.2002","article-title":"Experimental parkinsonism alters Endocannabinoid degradation: implications for striatal Glutamatergic transmission","volume":"22","author":"Gubellini","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2020.104807_bb0105","series-title":"Metabotropic Glutamate Receptors and Parkinson\u2019s Disease: Basic and Preclinical Neuroscience. mGLU Receptors","first-page":"33","author":"Gubellini","year":"2017"},{"key":"10.1016\/j.nbd.2020.104807_bb0110","doi-asserted-by":"crossref","first-page":"16541","DOI":"10.1523\/JNEUROSCI.3047-12.2012","article-title":"Levodopa-induced dyskinesia is strongly associated with resonant cortical oscillations","volume":"32","author":"Halje","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2020.104807_bb0115","first-page":"101","article-title":"Local field potentials: myths and misunderstandings","volume":"10","author":"Herreras","year":"2016","journal-title":"Front. Neural Circ."},{"key":"10.1016\/j.nbd.2020.104807_bb0120","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1124\/pr.111.005678","article-title":"The pharmacology of L-DOPA-induced dyskinesia in Parkinson\u2019s disease","volume":"65","author":"Huot","year":"2013","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.nbd.2020.104807_bb0125","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.neulet.2011.09.007","article-title":"Activation of group II metabotropic glutamate receptors induces long-term depression of excitatory synaptic transmission in the substantia nigra pars reticulata","volume":"504","author":"Johnson","year":"2011","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.nbd.2020.104807_bb0130","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/nature01374","article-title":"Brain-state-and cell-type-specific firing of hippocampal interneurons in vivo","volume":"421","author":"Klausberger","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2020.104807_bb0135","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1007\/PL00005284","article-title":"LY354740, a group II metabotropic glutamate receptor agonist with potential antiparkinsonian properties in rats","volume":"358","author":"Konieczny","year":"1998","journal-title":"Naunyn Schmiedeberg\u2019s Arch. Pharmacol."},{"key":"10.1016\/j.nbd.2020.104807_bb0140","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1002\/(SICI)1097-0193(1999)8:4<194::AID-HBM4>3.0.CO;2-C","article-title":"Measuring phase synchrony in brain signals","volume":"8","author":"Lachaux","year":"1999","journal-title":"Hum. Brain Mapp."},{"key":"10.1016\/j.nbd.2020.104807_bb0145","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1016\/j.neuron.2012.09.032","article-title":"Therapeutic deep brain stimulation in Parkinsonian rats directly influences motor cortex","volume":"76","author":"Li","year":"2012","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2020.104807_bb0150","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.pnpbp.2015.02.012","article-title":"Perspectives on the mGluR2\/3 agonists as a therapeutic target for schizophrenia: still promising or a dead end?","volume":"60","author":"Li","year":"2015","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.nbd.2020.104807_bb0155","doi-asserted-by":"crossref","first-page":"7537","DOI":"10.1523\/JNEUROSCI.1176-08.2008","article-title":"Inversion of dopamine responses in striatal medium spiny neurons and involuntary movements","volume":"28","author":"Liang","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2020.104807_bb0160","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.neuropharm.2016.03.036","article-title":"Metabotropic glutamate receptors as therapeutic targets in Parkinson's disease: an update from the last 5 years of research","volume":"115","author":"Litim","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.nbd.2020.104807_bb0165","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1002\/ana.23951","article-title":"Adaptive deep brain stimulation in advanced Parkinson disease","volume":"74","author":"Little","year":"2013","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2020.104807_bb0170","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1002\/1531-8257(200009)15:5<873::AID-MDS1017>3.0.CO;2-I","article-title":"Beneficial effects of amantadine on L-dopa-induced dyskinesias in Parkinson\u2019s disease","volume":"15","author":"Luginger","year":"2000","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2020.104807_bb0175","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1046\/j.0953-816x.2001.01843.x","article-title":"Pharmacological validation of behavioural measures of akinesia and dyskinesia in a rat model of Parkinson\u2019s disease","volume":"15","author":"Lundblad","year":"2002","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.nbd.2020.104807_bb0180","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.nbd.2004.01.007","article-title":"A model of L-DOPA-induced dyskinesia in 6-hydroxydopamine lesioned mice: relation to motor and cellular parameters of nigrostriatal function","volume":"16","author":"Lundblad","year":"2004","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2020.104807_bb0185","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s00726-001-0127-1","article-title":"Localization and physiological roles of metabotropic glutamate receptors in the direct and indirect pathways of the basal ganglia","volume":"23","author":"Marino","year":"2002","journal-title":"Amino Acids"},{"key":"10.1016\/j.nbd.2020.104807_bb0190","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1212\/WNL.50.5.1323","article-title":"Amantadine as treatment for dyskinesias and motor fluctuations in Parkinson\u2019s disease","volume":"50","author":"Metman","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2020.104807_bb0195","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0091-3057(02)00842-0","article-title":"Evaluation of the mGluR2\/3 agonist LY379268 in rodent models of Parkinson\u2019s disease","volume":"73","author":"Murray","year":"2002","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.nbd.2020.104807_bb0200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pneurobio.2008.09.013","article-title":"Priming for l-dopa-induced dyskinesia in Parkinson\u2019s disease: a feature inherent to the treatment or the disease?","volume":"87","author":"Nadjar","year":"2009","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.nbd.2020.104807_bb0205","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1097\/WCO.0000000000000034","article-title":"Synchronized neural oscillations and the pathophysiology of Parkinson\u2019s disease","volume":"26","author":"Oswal","year":"2013","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.nbd.2020.104807_bb0210","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1002\/ana.410390505","article-title":"Levodopa-induced dyskinesias improved by a glutamate antagonist in parkinsonia monkeys","volume":"39","author":"Papa","year":"1996","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2020.104807_bb0215","doi-asserted-by":"crossref","first-page":"3224","DOI":"10.1111\/j.1460-9568.2012.08243.x","article-title":"Anti-dyskinetic mechanisms of amantadine and dextromethorphan in the 6-OHDA rat model of Parkinson\u2019s disease: role of NMDA vs. 5-HT1A receptors","volume":"36","author":"Paquette","year":"2012","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.nbd.2020.104807_bb0220","first-page":"1","article-title":"Significance and translational value of high-frequency cortico-basal ganglia oscillations in Parkinson\u2019s disease","author":"Petersson","year":"2019","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.nbd.2020.104807_bb0225","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1002\/mds.27261","article-title":"Motor complications in Parkinson\u2019s disease: striatal molecular and electrophysiological mechanisms of dyskinesias","volume":"33","author":"Picconi","year":"2018","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2020.104807_bb0230","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.neuroscience.2013.07.010","article-title":"Reversal of novelty-induced hyperlocomotion and hippocampal c-Fos expression in GluA1 knockout male mice by the mGluR2\/3 agonist LY354740","volume":"250","author":"Procaccini","year":"2013","journal-title":"Neuroscience."},{"key":"10.1016\/j.nbd.2020.104807_bb0235","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0015298","article-title":"Amantadine for dyskinesias in Parkinson\u2019s disease: a randomized controlled trial","volume":"5","author":"Sawada","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.nbd.2020.104807_bb0240","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1080\/1025389031000146773","article-title":"LY354740, an mGlu2\/3 receptor agonist as a novel approach to treat anxiety\/stress","volume":"6","author":"Schoepp","year":"2003","journal-title":"Stress"},{"key":"10.1016\/j.nbd.2020.104807_bb0245","doi-asserted-by":"crossref","first-page":"9977","DOI":"10.1523\/JNEUROSCI.0658-17.2017","article-title":"A population of indirect pathway striatal projection neurons is selectively entrained to parkinsonian beta oscillations","volume":"37","author":"Sharott","year":"2017","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2020.104807_bb0250","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1152\/jn.00910.2014","article-title":"Dopamine regulates distinctively the activity patterns of striatal output neurons in advanced parkinsonian primates","volume":"113","author":"Singh","year":"2015","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.nbd.2020.104807_bb0255","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.celrep.2017.12.095","article-title":"Glutamatergic tuning of hyperactive striatal projection neurons controls the motor response to dopamine replacement in Parkinsonian Primates","volume":"22","author":"Singh","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.nbd.2020.104807_bb0260","doi-asserted-by":"crossref","first-page":"6445","DOI":"10.1523\/JNEUROSCI.1128-16.2016","article-title":"Gamma oscillations in the hyperkinetic state detected with chronic human brain recordings in Parkinson\u2019s disease","volume":"36","author":"Swann","year":"2016","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2020.104807_bb0265","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S0306-4522(01)00305-0","article-title":"Distribution of metabotropic glutamate receptor mGluR3 in the mouse CNS: differential location relative to pre-and postsynaptic sites","volume":"106","author":"Tamaru","year":"2001","journal-title":"Neuroscience."},{"key":"10.1016\/j.nbd.2020.104807_bb0270","first-page":"141","article-title":"Duration of amantadine benefit on dyskinesia of severe Parkinson\u2019s disease","volume":"75","author":"Thomas","year":"2004","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.nbd.2020.104807_bb0275","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.neuroscience.2014.01.042","article-title":"Effect of memantine on L-DOPA-induced dyskinesia in the 6-OHDA-lesioned rat model of Parkinson\u2019s disease","volume":"265","author":"Tronci","year":"2014","journal-title":"Neuroscience"},{"key":"10.1016\/j.nbd.2020.104807_bb0280","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/ane.12468","article-title":"Memantine and reduced time with dyskinesia in Parkinson\u2019s disease","volume":"133","author":"Wictorin","year":"2016","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.nbd.2020.104807_bb0285","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1006\/nbdi.2002.0499","article-title":"L-DOPA-induced dyskinesia in the intrastriatal 6-hydroxydopamine model of parkinson\u2019s disease: relation to motor and cellular parameters of nigrostriatal function","volume":"10","author":"Winkler","year":"2002","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2020.104807_bb0290","doi-asserted-by":"crossref","first-page":"417","DOI":"10.3389\/fncel.2018.00417","article-title":"TRH analog, Taltirelin improves motor function of hemi-PD rats without inducing dyskinesia via sustained dopamine stimulating effect","volume":"12","author":"Zheng","year":"2018","journal-title":"Front. Cell. Neurosci."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996120300826?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996120300826?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T05:18:10Z","timestamp":1760851090000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996120300826"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":58,"alternative-id":["S0969996120300826"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2020.104807","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Distinct anti-dyskinetic effects of amantadine and group II metabotropic glutamate receptor agonist LY354740 in a rodent model: An electrophysiological perspective","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2020.104807","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"104807"}}